Purchase Order 36C24224P1424

Award Date 7/16/24
Potential Completion Date 8/16/24
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10013, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded a $95,955 firm fixed price purchase order to Oxford Nanopore Technologies Inc. for a GRIDION MK1 sequencing machine. The sole source award is in response to solicitation 6505 for the intent to acquire a GridION Mk1 sequencing device from Nanopore Technologies for the James J. Peters VA Medical Center in Bronx, New York. The sequencing machine and associated assurance, software license,...
This is a $23,050.00 firm fixed price purchase order awarded to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services. The contract is for the delivery of a PromethION 2 Solo CAPEX Sequencing Unit, a next-generation genomic sequencing platform developed by Oxford Nanopore. This award is not associated with a set-aside program and is the latest in a...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a purchase order contract valued at one hundred thirty-two thousand sixty-two dollars to Oxford Nanopore Technologies Inc. for the acquisition of Oxford Nanopore sequencing devices and associated training and support. Per the solicitation, the Central Texas Veterans Health Care System Research Department sought to procure an Oxford Nanopore GridION sequencing device and PromethION...
This is a $95,605 firm-fixed-price purchase order awarded by the Southeast Area office of a civilian federal agency to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the GRIDLON X5-CAPEX genomic sequencing system and related products and services, with an ultimate completion date of October 4, 2019. The contract does not have a set-aside designation. Oxford Nanopore Technologies is a prime federal contractor that has secured numerous awards...
The U.S. Defense agency, the Bureau of Medicine and Surgery, awarded a $80,045.00 firm-fixed-price purchase order contract to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract, identified as N3239824P0044, is for the delivery of P2 INTEGRATED CAPEX and has an ultimate completion date of September 29, 2025. Oxford Nanopore Technologies provides next-generation genomic sequencing equipment, consumables, and associated services to various U.S....
Oxford Nanopore Technologies Inc. was awarded a firm fixed price purchase order in the amount of $12,500 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 to provide a license and warranty renewal for an Oxford Nanopore Gridion nanopore sequencing device. This purchase order was awarded non-competitively pursuant to Federal Acquisition Regulation 6.302-1 as Oxford Nanopore Technologies Inc. was determined to be the only responsible...
This is a $12,550.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the license and warranty of a GridION sequencing device, with an ultimate completion date of August 1, 2025. Oxford Nanopore Technologies has secured numerous federal contract awards to supply next-generation genomic sequencing equipment, consumables, and associated...
This federal contract award to Oxford Nanopore Technologies Inc., a division of Oxford Nanopore Technologies PLC, is for the procurement of a PromethION high throughput sequencing system. The $134,999.99 firm-fixed price purchase order was awarded by the U.S. Department of Agriculture's Animal and Plant Health Inspection Service Veterinary Services and has a completion date of September 30, 2018. The contract does not have a set-aside designation. Oxford Nanopore Technologies Inc. is an...
The Department of Health and Human Services Food and Drug Administration awarded a $116,289.00 firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, to procure a long-read DNA sequencing instrument and associated automated library preparation instrument. The contract has no set-aside designation. The requirement was originally solicited through a competitive process, with Oxford Nanopore securing the award on September 16, 2021. Oxford...
This is a firm fixed-price purchase order contract awarded by the Veterinary Services division of the U.S. Department of Agriculture (USDA) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, for the delivery of sequencing systems. The contract has a ceiling value of $560,905.00 and a completion date of December 7, 2023. Oxford Nanopore Technologies has provided genomic sequencing equipment, consumables, and services to various federal agencies, including...

The Department of Veterans Affairs, James J. Peters VA Medical Center has awarded a $23,050 firm-fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, for the PromethION 2 Solo CapEx sequencing device to support the SeqCURES research laboratory. This procurement was conducted as a sole source under FAR 13.106-1(b)(1)(ii) due to the unique technical capabilities of Oxford Nanopore's sequencing platforms. Oxford Nanopore has secured numerous federal contract awards to supply next-generation genomic sequencing equipment and associated services to various U.S. government agencies, including the NIH, CDC, USDA, and DOD, to support diverse research initiatives. The contract has a period of performance of 30 days after award and does not utilize any set-aside designations.

Generated 9/5/24, 9:20 AM